{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:37:29Z","timestamp":1791401849692,"version":"4.3.3"},"reference-count":48,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T00:00:00Z","timestamp":1508112000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Flexion Therapeutics, Inc"},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Bioiberica"},{"name":"Flexion Therapeutics, Inc."},{"name":"Infirst"},{"name":"Merck-Serono"},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Janssen"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"crossref"}]},{"name":"UCB"},{"name":"Flexion Therapeutics, Inc."},{"name":"Flexion Therapeutics, Inc."},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research (NIHR) Leeds Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.joca.2017.10.003","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T13:20:23Z","timestamp":1507814423000},"page":"34-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA)"],"prefix":"10.1016","volume":"26","author":[{"given":"V.B.","family":"Kraus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.G.","family":"Conaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A.","family":"Aazami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Kivitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lufkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hauben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bodick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2017.10.003_bib1","series-title":"Osteoarthritis: A Serious Disease","author":"Osteoarthritis Research Society International","year":"2016"},{"issue":"5 Suppl 51","key":"10.1016\/j.joca.2017.10.003_bib2","first-page":"S120","article-title":"Mortality in osteoarthritis","volume":"26","author":"Hochberg","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.joca.2017.10.003_bib3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/annrheumdis-2014-205894","article-title":"Synovitis in knee osteoarthritis: a precursor of disease?","volume":"75","author":"Atukorala","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.joca.2017.10.003_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/ard.2009.121426","article-title":"Relation of synovitis to knee pain using contrast-enhanced MRIs","volume":"69","author":"Baker","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.joca.2017.10.003_bib5","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/ard.2010.139618","article-title":"Assessment of synovitis with contrast-enhanced MRI using a whole-joint semiquantitative scoring system in people with, or at high risk of, knee osteoarthritis: the MOST study","volume":"70","author":"Guermazi","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.joca.2017.10.003_bib6","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1136\/ard.2006.067470","article-title":"Synovitis detected on magnetic resonance imaging and its relation to pain and cartilage loss in knee osteoarthritis","volume":"66","author":"Hill","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.joca.2017.10.003_bib7","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1002\/art.30471","article-title":"Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritis","volume":"63","author":"Krasnokutsky","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.joca.2017.10.003_bib8","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1136\/ard.2011.150243","article-title":"Presence of MRI-detected joint effusion and synovitis increases the risk of cartilage loss in knees without osteoarthritis at 30-month follow-up: the MOST study","volume":"70","author":"Roemer","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.joca.2017.10.003_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/art.30137","article-title":"Synovial inflammation in patients undergoing arthroscopic meniscectomy: molecular characterization and relationship to symptoms","volume":"63","author":"Scanzello","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.joca.2017.10.003_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2106\/JBJS.I.00667","article-title":"Associations of anatomical measures from MRI with radiographically defined knee osteoarthritis score, pain, and physical functioning","volume":"93","author":"Sowers","year":"2011","journal-title":"J\u00a0Bone Jt Surg Am"},{"issue":"10","key":"10.1016\/j.joca.2017.10.003_bib11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.joca.2006.03.015","article-title":"The relationship between specific tissue lesions and pain severity in persons with knee osteoarthritis","volume":"14","author":"Torres","year":"2006","journal-title":"Osteoarthritis Cartilage"},{"issue":"9","key":"10.1016\/j.joca.2017.10.003_bib12","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1136\/ard.2004.025270","article-title":"Synovial tissue inflammation in early and late osteoarthritis","volume":"64","author":"Benito","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.joca.2017.10.003_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","article-title":"Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis","volume":"12","author":"Robinson","year":"2016","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.joca.2017.10.003_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.bone.2012.02.012","article-title":"The role of synovitis in osteoarthritis pathogenesis","volume":"51","author":"Scanzello","year":"2012","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.joca.2017.10.003_bib15","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrrheum.2010.159","article-title":"The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis","volume":"6","author":"Sellam","year":"2010","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.joca.2017.10.003_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/1759720X10378373","article-title":"The role of synovitis in osteoarthritis","volume":"2","author":"Wenham","year":"2010","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"5","key":"10.1016\/j.joca.2017.10.003_bib17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00002281-199909000-00016","article-title":"Intra-articular corticosteroid treatment in osteoarthritis","volume":"11","author":"Creamer","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.joca.2017.10.003_bib18","article-title":"Intra-articular corticosteroid for knee osteoarthritis","volume":"10","author":"J\u00fcni","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"10.1016\/j.joca.2017.10.003_bib19","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/art.1780381103","article-title":"Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology","volume":"38","author":"Hochberg","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.joca.2017.10.003_bib20","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/art.1780381104","article-title":"Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology","volume":"38","author":"Hochberg","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.joca.2017.10.003_bib21","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2003.011742","article-title":"EULAR recommendations 2003: an evidence based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)","volume":"62","author":"Jordan","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.joca.2017.10.003_bib22","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Anti-inflammatory actions of glucocorticoids: molecular mechanisms","volume":"94","author":"Barnes","year":"1998","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.1016\/j.joca.2017.10.003_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nsmb.2456","article-title":"The structural basis of direct glucocorticoid-mediated transrepression","volume":"20","author":"Hudson","year":"2013","journal-title":"Nat Struct Mol Biol"},{"issue":"1","key":"10.1016\/j.joca.2017.10.003_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.steroids.2012.09.013","article-title":"It takes two to tango: dimerization of glucocorticoid receptor and its anti-inflammatory functions","volume":"78","author":"Nixon","year":"2013","journal-title":"Steroids"},{"issue":"11","key":"10.1016\/j.joca.2017.10.003_bib25","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/ard.56.11.634","article-title":"Intra-articular corticosteroid injections in osteoarthritis: do they work and if so, how?","volume":"56","author":"Creamer","year":"1997","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.joca.2017.10.003_bib26","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0165-6147(93)90184-L","article-title":"Anti-inflammatory actions of steroids: molecular mechanisms","volume":"14","author":"Barnes","year":"1993","journal-title":"Trends Pharmacol Sci"},{"issue":"4","key":"10.1016\/j.joca.2017.10.003_bib27","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/rheumatology\/19.4.212","article-title":"Intra-articular steroids in osteoarthritis","volume":"19","author":"Dieppe","year":"1980","journal-title":"Rheumatol Rehabil"},{"issue":"7","key":"10.1016\/j.joca.2017.10.003_bib28","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1136\/thorax.55.7.603","article-title":"Molecular mechanisms of glucocorticoid action: what is important?","volume":"55","author":"Newton","year":"2000","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.joca.2017.10.003_bib29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/annrheumdis-2014-206927","article-title":"Synovial tissue volume: a treatment target in knee osteoarthritis (OA)","volume":"75","author":"O'Neill","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.joca.2017.10.003_bib30","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5312\/wjo.v5.i3.351","article-title":"Intraarticular injections (corticosteroid, hyaluronic acid, platelet rich plasma) for the knee osteoarthritis","volume":"5","author":"Ayhan","year":"2014","journal-title":"World J Orthop"},{"key":"10.1016\/j.joca.2017.10.003_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2474-8-51","article-title":"Short-term efficacy of physical interventions in osteoarthritic knee pain. A systematic review and meta-analysis of randomised placebo-controlled trials","volume":"8","author":"Bjordal","year":"2007","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.joca.2017.10.003_bib32","first-page":"241","article-title":"Intra-articular steroid injections for painful knees. Systematic review with meta-analysis","volume":"50","author":"Godwin","year":"2004","journal-title":"Can Fam Physician"},{"issue":"3","key":"10.1016\/j.joca.2017.10.003_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/clpt.1986.45","article-title":"Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration","volume":"39","author":"Derendorf","year":"1986","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.joca.2017.10.003_bib34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.joca.2007.12.013","article-title":"OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines","volume":"16","author":"Zhang","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"issue":"S63\u2013312","key":"10.1016\/j.joca.2017.10.003_bib35","article-title":"FX006 prolongs the residency of triamcinolone acetonide in the synovial tissues of patients with knee osteoarthritis","volume":"21","author":"Bodick","year":"2013","journal-title":"Osteoarthritis Cartilage"},{"issue":"A82e416","key":"10.1016\/j.joca.2017.10.003_bib36","article-title":"Prolonged joint residency of triamcinolone acetonide after an intra-articular injection of FX006, a sustained release formulation for the treatment of osteoarthritis","volume":"23","author":"Conaghan","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"issue":"11","key":"10.1016\/j.joca.2017.10.003_bib37","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2106\/JBJS.N.00918","article-title":"An intra-articular, extended-release formulation of triamcinolone acetonide prolongs and amplifies analgesic effect in patients with osteoarthritis of the knee: a randomized clinical trial","volume":"97","author":"Bodick","year":"2015","journal-title":"J\u00a0Bone Joint Surg Am"},{"issue":"8","key":"10.1016\/j.joca.2017.10.003_bib38","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the knee","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2017.10.003_bib39","doi-asserted-by":"crossref","unstructured":"Conaghan PG, Hunter DJ, Cohen SB, Kraus VB, Berenbaum F, Lieberman JR, et al. Effects of a single intra-articular injection of a microsphere-formulation of triamcinolone acetonide on knee osteoarthritis pain. A double-blind, randomized, placebo-controlled, multinational study. Accepted 2017. In press.","DOI":"10.2106\/JBJS.17.00154"},{"key":"10.1016\/j.joca.2017.10.003_bib40","series-title":"Treatment of Osteoarthritis of the Knee. Evidence-based Guideline","author":"American Academy of Orthopaedic Surgeons","year":"2013"},{"issue":"1","key":"10.1016\/j.joca.2017.10.003_bib41","first-page":"131","article-title":"Minimal clinically important rehabilitation effects in patients with osteoarthritis of the lower extremities","volume":"29","author":"Angst","year":"2002","journal-title":"J\u00a0Rheumatol"},{"issue":"10","key":"10.1016\/j.joca.2017.10.003_bib42","first-page":"2025","article-title":"Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues","volume":"32","author":"Tubach","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.joca.2017.10.003_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.joca.2014.09.019","article-title":"Sustained efficacy of a single intra-articular dose of FX006 in a rat model of repeated localized knee arthritis","volume":"23","author":"Kumar","year":"2015","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"10.1016\/j.joca.2017.10.003_bib44","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/ard.2003.009944","article-title":"Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis","volume":"63","author":"Metselaar","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2017.10.003_bib45","series-title":"Statistical Approaches to Establishing Bioequivalence","author":"U.S. Department of Health and Human Services, Food and Drug Administration","year":"2001"},{"issue":"Suppl 1","key":"10.1016\/j.joca.2017.10.003_bib46","first-page":"A289","article-title":"In type 2 diabetes mellitus patients with knee osteoarthritis intra-articular injection of FX006 (Extended Release Triamcinolone) is associated with reduced blood glucose elevation vs. standard triamcinolone; a randomized, blinded, parallel-group study","volume":"66","author":"Russell","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.joca.2017.10.003_bib47","article-title":"Phase 2b trial of a novel extended-release microsphere formulation of triamcinolone acetonide for intra-articular injection in knee osteoarthritis","author":"Conaghan","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.joca.2017.10.003_bib48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Shive","year":"1997","journal-title":"Adv Drug Deliv Rev"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458417312268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458417312268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:46:39Z","timestamp":1761018399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458417312268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S1063458417312268"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2017.10.003","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA)","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2017.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.","name":"copyright","label":"Copyright"}]}}